2015
DOI: 10.1016/j.freeradbiomed.2014.12.021
|View full text |Cite
|
Sign up to set email alerts
|

Thioredoxin is a novel diagnostic and prognostic marker in patients with ischemic stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
20
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(26 citation statements)
references
References 39 publications
4
20
1
Order By: Relevance
“…Functional outcome was assessed by the modified Rankin Scale (mRS) [23] blinded to serum biomarkers. A favorable functional outcome was defined as a mRS of 0-2 points, whereas an unfavorable outcome was defined as a mRS of >2 points [24]. Secondary end-points were all-cause mortality within 3 months.…”
Section: End Points and Follow-upmentioning
confidence: 99%
“…Functional outcome was assessed by the modified Rankin Scale (mRS) [23] blinded to serum biomarkers. A favorable functional outcome was defined as a mRS of 0-2 points, whereas an unfavorable outcome was defined as a mRS of >2 points [24]. Secondary end-points were all-cause mortality within 3 months.…”
Section: End Points and Follow-upmentioning
confidence: 99%
“…skeletal muscle [116]). As an exception, redox enzyme content in plasma may be useful biomarkers in health and disease [117], [118], [119]. For example, elevated serum PRDX4 content is regarded as a novel stroke risk factor [118].…”
Section: Redox Enzymes In Plasmamentioning
confidence: 99%
“…As an exception, redox enzyme content in plasma may be useful biomarkers in health and disease [117], [118], [119]. For example, elevated serum PRDX4 content is regarded as a novel stroke risk factor [118]. Redox enzyme content can be easily assessed using quantitative immunoblotting [120].…”
Section: Redox Enzymes In Plasmamentioning
confidence: 99%
“…Mortality after 1 year ranges between 21% and 27%; 15% to 30% of survivors are permanently disabled [2]. An early risk assessment with estimate of the severity of disease and prognosis is pivotal for optimized care and allocation of healthcare resources to improve outcome [3].…”
Section: Introductionmentioning
confidence: 99%